Synutra International (SYUT) Stock Price, News & Analysis

Company Overview

Synutra International, Inc. is an infant formula company in China. The Company is engaged in the production, distribution and sale of dairy-based nutritional products under the Shengyuan or Synutra line of brands. The Company operates through three segments: Nutritional Food, which includes the sale of powdered infant and adult formula products, with brands, including Super, My Angel and Dutch Cow, as well as the sale of prepared foods under the brand of Huiliduo; Nutritional Supplement, which includes the production and sale of nutritional supplements, such as chondroitin sulfate to third-parties and microencapsulated Docosahexanoic Acid and Arachidonic Acid to the nutritional food segment for use in powdered formula production, and Other Business, which includes non-core businesses, such as ancillary sales of excess or unusable ingredients and materials to industrial customers; provision of genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women.

Key Stats

• Today's Range: $6.05 to $6.05
• 50-Day Range: N/A
• 52-Week Range: $3.24 to $6.05
• Volume: N/A
• Average Volume: 160,650 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SYUT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Synutra International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Synutra International investors own include Lifeway Foods (LWAY), Alliance Fiber Optic Products (AFOP), Alliance Resource Partners (ARLP), Avino Silver & Gold Mines (ASM), Galapagos (GLPG), General Motors (GM) and Herbalife (HLF).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Personal Products
• Current Symbol: NASDAQ:SYUT
• CIK: 1293593
• Web: www.synutra.com
• Phone: +1-301-8403888
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A